GET THE APP

Design, synthesis, docking and evolution of fused imidazoles as antiinflammatory and antibacterial agents | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Design, synthesis, docking and evolution of fused imidazoles as antiinflammatory and antibacterial agents

Author(s): Galal A. M. Nawwar, Nabil M. Grant, Randa H. Swellem and Samia A. M. Elseginy

New benzimidazole and imidzopyridine derivatives were designed and synthesized from their corresponding oximes II. The newly synthesized compounds were investigated in vivo for their anti-inflammatory and analgesic activities. Some of the new compounds (IVc, IVf, IVi) showed reasonable anti-inflammatory and analgesic activity in experimental rats in comparing to indomethacin and Diclofenac Na, as reference drugs Moreover, some of the newly synthesized compounds tested as antimicrobial agents, IVh exhibited potent antimicrobial activities with low MIC in comparing with Cefoperazone and Fluconazole as reference drugs Docking studies was carried out for derivatives of highest anti-inflammatory activity into the COX-2 binding site. Designed compounds IVc,IVf,IVi revealed a similar binding mode to COX-2 inhibitor.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry